Global Medical REIT Inc expected to post breakeven results a share - Earnings Preview

Chiron Real Estate

03/08/2024 03:04

* Global Medical REIT Inc  GMRE.N   GMRE.K  is expected
to show a
fall in quarterly revenue when it reports  results on August 6
for the period ending June 30 2024
    * The Bethesda Maryland-based  company is expected to report
a
5.3% decrease in revenue to $34.436 million from $36.35 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Global Medical REIT Inc
is for
breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Global
Medical
REIT Inc is $10.00​, above​ its last closing price of $9.48. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  0.21        0.21       0.21      Met     0.6
 Dec. 31 2023  0.22        0.22       0.19      Missed  -13.2
 Sep. 30 2023  0.21        0.21       0.22      Beat    4.2​
 Jan. 1 0001   0.22        0.23       0.21      Missed  
 ​​Jan.                    0.23       0.22      Missed  -5.3
 1 0001                                                 
 Dec. 31 2022              0.23       0.22      Missed  -6.2​
 Sep. 30 2022              0.24       0.23      Missed  
 Jun. 30 2022              0.24       0.24      Met     
 This summary was machine generated August 3 at 02:04 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)